Assessment the efficacy of atomoxetin(stramox) in autism spectrum disorders
Phase 2
- Conditions
- Autism spectrum disorders.Childhood autismF84.0, F84
- Registration Number
- IRCT2016022826802N1
- Lead Sponsor
- Vice chancellor for research of mashhad university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
The inclusion criteria: Of all patients with ASD, ranging in age from 6 to 17 years; Parent's Consent; No obvious organic disease; The lack of other psychiatric disorders; Not taking other psychoactive medications other than risperidone; IQ higher than 50 on the basis of Weiland test
The exclusion criteria: In the absence of cooperation of parents after inclusion; the risk of any side effect or another disease that cause a problem in results.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Autism. Timepoint: Previous the syudy, 4 weeks after study, 8 weeks after study. Method of measurement: CARS test,CGI test.
- Secondary Outcome Measures
Name Time Method Drug's side effect. Timepoint: Previous the study, 4weeks after study, 8 weeks after study. Method of measurement: Check list.